Medical devices, kits, and methods of manufacturing medical devices
By combining hydrogel materials with felt patches, the problem of inaccurate drug release in existing technologies is solved, achieving targeted drug release and mechanical stability, which is suitable for soft tissue repair and closure.
Patent Information
- Application Number
- CN202580027076.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-04-09
- Filing Date
- 2025-03-28
- Publication Date
- 2026-11-17
AI Technical Summary
Existing medical devices struggle to achieve precise targeted release and uniform distribution of drugs when fixing implants to soft tissues, and the microstructure and material properties of porous structures limit the control of drug dosage and release profiles.
The implant combines a patch with a felt containing hydrogel material. The hydrogel material is configured to retain active ingredients and release them in response to triggering factors. This forms an implant that provides mechanical stability and uniformly distributed anchoring, and enables targeted release of active ingredients and a predetermined release curve.
It achieves targeted release and uniform distribution of drugs, provides mechanical stability, adapts to soft tissue shapes, and meets clinical application needs through the responsive release of active ingredients via hydrogel.
Smart Images

Figure CN123125002A_ABST
Abstract
Description
[0001] This invention relates to a medical device, a kit, and a method of manufacturing the medical device.
[0002] The applicant has developed a novel surgical felting instrument that offers biomechanical advantages in securing implants to soft tissue compared to traditional suturing methods. The instrument comprises a surgical instrument equipped with surgical felt needles that can repeatedly pass through the surgical felt of the implant and into the tissue. By embedding the felt fibers within the tissue, the instrument establishes a strong and uniformly distributed mechanical connection between the felt and the soft tissue.
[0003] During surgical procedures, if implants are secured to soft tissue using surgical instruments, additional measures may be required to enhance biocompatibility, promote healing, or improve other functions. This may involve administering medication before or after felting, but this can be cumbersome and may result in drug diffusion into unintended areas. Surgical felts have a fibrous, porous structure. Due to these properties, they can be used as carriers for drugs or bioactive agents to release medication after the medical felt is attached to the tissue, as described, for example, in WO 2023 / 232780. The fibers of the felt may contain medication. For example, the fibers may consist of or contain medication. The medication may be adsorbed or absorbed by the fibers.
[0004] Drugs may also be in a solid state and form an integral part of the fiber. Therefore, this mechanism allows for direct delivery of drugs to soft tissues, enabling targeted drug delivery while simultaneously providing strong mechanical fixation. Drugs can be distributed between and / or around the filamentous structures of the fiber, for example, by soaking, spraying, or sprinkling drug powder onto the fiber.
[0005] In most clinical cases involving soft tissue repair or closure, surgical felting instruments are typically used to mechanically fix the defect by felting a patch onto the soft tissue. However, the addition of biological agents or drugs is often necessary to promote healing, prevent infection, or relieve pain, but currently, most surgical patches or meshes do not have such biological agents or drugs available. Some porous patches, such as those described in patent application WO 2023 / 232780, can carry a certain amount of drug or bioactive agent. However, the microstructure of the porous structure and the surface properties of the material and fibers limit the precise control of drug dosage and release profiles, thus limiting their clinical application, especially when felting the patch onto soft tissue.
[0006] The present invention aims to overcome the aforementioned drawbacks of the prior art. Specifically, the present invention aims to provide a medical device capable of being felted and releasing a drug according to a predetermined release curve. This problem is solved by the features in each independent claim.
[0007] A first aspect of this disclosure relates to an implantable medical device for tissue repair or closure. The device includes a patch and a hydrogel material. The patch includes a felt for tissue repair or closure. The hydrogel material is configured to retain an active ingredient. The hydrogel material may be biodegradable and has a predetermined biodegradation rate, thereby releasing the active ingredient. The hydrogel material may also be configured to release the active ingredient in response to a triggering factor. In some embodiments, the hydrogel material degrades in response to a triggering factor.
[0008] The disclosed patch provides targeted drug delivery within a feltable patch. The combination of hydrogel and felt forms an implant that provides mechanical stability, enables uniform anchoring, and allows for precise targeted release of the active ingredient at the target site, and releases it in a predetermined manner. The device disclosed in this invention is compatible with the soft tissue felting technology developed by the applicant, while utilizing hydrogel to release the active ingredient. Hydrogels with fibers having high yield strength (100 kPa or higher) may be particularly suitable for felting.
[0009] The medical device can be an implant. The implant can be designed to remain inside the human (or animal) body after surgery. The medical device can be sheet-like. The device can have flexible tensile strength, meaning it can bend to conform to the shape of soft tissue.
[0010] The hydrogel material may include a cross-linked fiber network. The hydrogel material is water-retaining. The hydrogel material may include a polymer. The hydrogel material can retain at least 10% of its own weight in water. Preferably, the swelling ratio of the hydrogel is at least 1, 2, 5, or 10 times its own weight. In some embodiments, the swelling ratio of the hydrogel is at least 12, 15, 18, or 20 times its own weight. The swelling ratio can be calculated by dividing the weight of the absorbed water by the weight of the hydrogel material before swelling.
[0011] Preferably, the instrument is configured to be feltable. The felt can be configured to be feltable if the fibers have the strength described below. However, more generally, the felt (or hydrogelled material or hydrogel) can be configured to be feltable if the fibers can be pushed or pulled into soft tissue by felting needles. In particular, felting can be performed using reciprocating felting needles, as will be described in an example below.
[0012] Preferably, the hydrogel material comprises or is made of natural polymers or synthetic polymers or combinations thereof.
[0013] Preferably, the natural polymer comprises or is at least one of the following: cellulose (especially bacterial cellulose), alginate, hyaluronic acid (HA), gelatin, agar, agarose, starch, chitosan, and fibrinogen. These polymers are particularly suitable for the desired release profile. Carboxymethyl cellulose (CMC) is a specific example.
[0014] Preferably, the synthetic polymer is at least one of the following: acrylamide, acrylic acid, acrylate, and 2-hydroxyethyl methacrylate (PHEMA). These polymers are particularly suitable for achieving the desired release profile.
[0015] Preferably, the hydrogelling material forms a hydrogel and can partially absorb water and swell. The hydrogel can be a gel in which water is the swelling agent. The term "hydrogelling material" as used herein can refer to a material with water-retaining capacity, without requiring it to actually contain water. In some cases, the user (e.g., a clinical user such as a doctor or nurse) can cause the hydrogelling material to swell and form a hydrogel; in other cases, the hydrogelling material may swell during the manufacturer's on-site fabrication of the disclosed device. Hydrogelling material can also refer to a cross-linked but not fully swollen material.
[0016] Swelling hydrogel materials into hydrogels may involve loading active ingredients into the hydrogel.
[0017] The active ingredient can be hydrophilic. The active ingredient can be water-soluble. The active ingredient can be a small molecule drug (e.g., ≤1000 Daltons). Small molecule drugs may diffuse more easily into the hydrogel. The chemical properties of the active ingredient can be matched to the hydrogel to avoid drug molecules causing degradation or alteration of the hydrogel structure. The charge of the active ingredient can be matched to the hydrogel. For example, anionic hydrogels can be used in combination with positively charged active ingredients, and / or cationic hydrogels can be used in combination with negatively charged active ingredients (anions).
[0018] Preferably, the hydrogelling material forms a hydrogel, and the hydrogel swells sufficiently with water. The hydrogel may contain active ingredients dissolved or otherwise present in water (e.g., suspended and / or emulsified).
[0019] Preferably, the active ingredient is water-based, particularly soluble in the water contained in the hydrogel. Preferably, the active ingredient is dispersed, suspended, and / or emulsified in the water contained in the hydrogel. Thus, the active ingredient can be loaded into the disclosed device.
[0020] Preferably, the active ingredient is at least one of the following: a drug, a bioactive ingredient, and a biological agent.
[0021] Preferably, the active ingredient comprises or is at least one of the following: growth factors, differentiation factors, anti-allergens, corticosteroids, stem cells, anti-adhesion molecules, analgesics, anti-inflammatory agents, antibiotics, insulin, hormones, hyaluronic acid, mRNA or mRNA-based drugs, cytotoxic drugs, and vitamins.
[0022] In addition, the active ingredient includes or is at least one of the following: siRNA drugs, verteporfen, genipin, antacids, anxiolytics, antiarrhythmics, antibacterial drugs, coagulants, anticoagulants, thrombolytics, anticonvulsants, antidiarrheals, antiemetics, antifungals, antihistamines, antihypertensives, anti-inflammatory drugs, antitumor drugs, antipsychotics, antipyretics, antiviral drugs, barbiturates, beta-blockers, bronchodilators, cold medicines, cough suppressants, decongestants, diuretics, expectorants, hypoglycemic agents, immunosuppressants, laxatives, muscle relaxants, sedatives, sex hormones, hypnotics, and tranquilizers.
[0023] Preferably, the degradation rate of the hydrogel material is 2 to 48 hours, 2 to 14 days, 2 to 8 weeks, or 1 to 18 months in vivo. The desired degradation may depend on the application and can be modulated by the hydrogel material. Li, J., Mooney, D. Designing hydrogels for controlled drug delivery. Nat Rev Mater 1, 16071 (2016) discloses an exemplary method for modulating the degradation of hydrogel materials.
[0024] Preferably, the triggering factor should be at least one of the following: pH change, temperature, one or more enzymes, electric field, and mechanical stress, especially shear stress.
[0025] Preferably, the triggering factor leads to the degradation of the hydrogel material or the hydrogel.
[0026] Preferably, the felt and the hydrogel material are directly bonded together. For example, the felt and the hydrogel material can be felted together without the use of stitches or other additional fixing means (such as clamps). Additional fixing devices may restrict the felted area, thereby reducing the distribution of force.
[0027] Preferably, the connection can be at least one of a mechanical connection, a chemical connection, or a thermal connection.
[0028] Preferably, the fibers of the hydrogel material and the fibers of the felt are intertwined and / or entangled. The fibers of the hydrogel material and the fibers of the felt can be felted together. This forms a well-distributed connection between the hydrogel material and the felt fibers. Furthermore, this connection is particularly suitable for implanting the device using the felting technique described in the applicant's previous applications (e.g., PCT / EP2024 / 055924). Other felting devices suitable for the disclosed device are disclosed in any of the following applications: PCT / CH2019 / 000015, PCT / EP2020 / 081887, PCT / EP2020 / 081891, and PCT / EP2020 / 081881 (all filed by the applicant). In some embodiments, the needle may have a blunt or flattened tip, as described in EP23159745.1.
[0029] By intertwining and / or weaving the fibers of the felt and hydrogel material together, unwanted interactions can be prevented between the hydrogel material and the felt needle at the junction with the felt during implantation.
[0030] Preferably, the hydrogel material comprises or is made of fibers with a yield strength of at least 100, 250, or 500 kPa or at least 1, 10, or 100 MPa. Such fibers may be particularly advantageous because they may be compatible with felting processes, i.e., such fibers can be pushed or pulled by felting needles.
[0031] Preferably, the hydrogel material comprises or is composed of fibers with a tensile strength between 0.5 and 9 cN / dtex. In particular, the strength of the fibers can be greater than 1 cN / dtex.
[0032] Preferably, the patch comprising felt (or a layer comprising felt) has at least one of the following characteristics: a thickness of 0.2 to 3 mm, particularly 1.0 to 1.8 mm; a areal density of 10 to 500 g / m², particularly 200 to 400 g / m²; a tensile strength of 50 to 1200 N, particularly 400 to 800 N; and a stiffness of 10 to 500 N / mm², particularly 50 to 250 N / mm². Preferably, the felt comprises or is made of fibers with a strength between 0.5 and 10 centinewtons (cN / dtex), particularly 3 to 9 centinewtons (cN / dtex). Such felts are particularly suitable for felting onto soft tissues and can form a good mechanical bond between the felt and the soft tissue.
[0033] Hydrogel materials and felt can be sewn together, which can provide (additional) fixation.
[0034] Furthermore, the hydrogel material and the felt can be interconnected by cross-linking the hydrogel material within the felt. This can form a composite (or combined) hydrogel-felt material. This material is particularly useful because it improves workability, and the felt can be directly adhered to soft tissue.
[0035] Preferably, the hydrogel material and the felt are laminated together, particularly by heating the opposing surfaces of the hydrogel material and the felt material. This can provide an alternative or additional bonding mechanism between the hydrogel material and the felt.
[0036] Preferably, the felt comprises or is composed of the following fibers: polyethylene terephthalate (PET), polylactic acid (PLA), polyglutamic acid (PGA), hyaluronic acid (HA), polydioxane (PDO), polylactic acid-glycolic acid copolymer (PLGA), polytetrafluoroethylene (PTFE), polycaprolactone (PCL), chitosan, poly-D-lactic acid (PDLA), poly-DL-lactic acid (PDLLA), or poly-L-lactic acid (PLLA).
[0037] Preferably, the patch comprises a first layer containing felt. The first layer may include a plurality of pores in which a hydrogel material may be disposed. Thus, a single layer can provide mechanical stability and achieve a predetermined release profile of the active ingredient.
[0038] Preferably, the device comprises a first layer containing a felt and a second layer containing a hydrogel material. These two layers can be stacked on top of each other. This provides a device that is easy to manufacture, compact in structure, and has a predetermined active ingredient release profile.
[0039] Preferably, the first layer includes an edge region. This edge region can be folded around the second layer. In other embodiments, the device includes multiple (e.g., 2, 3, 4) edge regions folded around the second layer. Thus, the hydrogel material can be retained in situ, and the release of the active ingredient can be delayed.
[0040] Preferably, the second layer also includes a frame made of felt. The hydrogel material can be contained within and surrounded by this frame. This allows the hydrogel material to remain in situ, and the release of the active ingredient can be delayed. Furthermore, the operation of the device can be simplified.
[0041] Preferably, the device includes a third layer. The third layer may include felt, such as the same felt as the first layer or a different felt. The third layer may also additionally or alternatively include a hydrogelling material. The hydrogelling material may be the same as or a different hydrogelling material in the second layer. The layers may be arranged in the following order: first layer (felt), second layer (hydrogelling material), third layer (felt). The layers may also be arranged in other orders: third layer (hydrogelling material), first layer (felt), second layer (hydrogelling material) or third layer (felt), first layer (felt), second layer (hydrogelling material).
[0042] Preferably, the second layer, namely the hydrogel material, is sandwiched between the two layers containing the felt. This allows for a particularly slow release profile. Furthermore, the hydrogel material is stable, and hydrogel materials with poor mechanical stability can be selected.
[0043] Preferably, the third layer comprises a hydrogel material, and a capsule is provided between the second and third layers. This capsule can also be used to store active ingredients that are not retained by water, such as active ingredients in a solid, gaseous, or liquid state other than water. Thus, a large quantity of active ingredients can be delivered to the target site.
[0044] Preferably, the capsule contains an active ingredient. The active ingredient may be solid or gaseous. The capsule may include a liner made of or containing a hydrogelatinized material. The hydrogelatinized material constituting the capsule may at least partially swell to form a hydrogel. The swelling of the hydrogelatinized material prevents the active ingredient, in solid or gaseous form, from escaping from the capsule.
[0045] Preferably, the device comprises a first layer made of felt and a second layer made of a hydrogel material. The first layer may include a first surface and an opposite second surface. The second layer may include one or more stripes that pass through the first layer, extend from the first surface to the opposite second surface, and return. Thus, the second layer can be interwoven within the first layer. This allows for the fixation of a large amount of the second layer, thereby fixing a large amount of the hydrogel material.
[0046] Preferably, the device is configured for tendon repair, ligament repair, muscle repair, fascia repair, skin repair, hernia repair, gastrointestinal surgery, cardiac surgery, vascular surgery, or dental surgery.
[0047] Preferably, the device is configured to seal internal wounds. In particular, the hydrogel material is preferably configured to seal internal wounds. Specifically, the hydrogel material can be configured to seal the wound upon swelling (i.e., upon forming a hydrogel). Thus, the wound (e.g., a laceration) can simultaneously achieve mechanical stability, active ingredient treatment, and sealing.
[0048] Preferably, the internal wound can be at least one of the following: tendon rupture or tear, ligament rupture or tear, abdominal wall opening that closes the abdominal cavity, or gastrointestinal wall opening.
[0049] Another aspect of the invention relates to a kit comprising the apparatus and felting apparatus as described above. The felting apparatus may be the felting apparatus described in PCT / EP2024 / 055924.
[0050] The felting device may include a felting needle configured to insert a single fiber into soft tissue. The felting needle is reciprocating between an extended position and a retracted position. In the extended position, the working tip of the felting needle extends beyond the orifice of the felting device. This orifice may be located at the distal end of the felting device. In the retracted position, the working tip of the felting needle does not extend beyond the orifice. The extended and retracted positions may be the endpoints of the reciprocating motion. The felting needle may be connected to a drive mechanism with a force-limiting element. During operation, as the working tip moves from the retracted position to the extended position, the force-limiting element limits the force applied to the felting needle by the drive mechanism within a predetermined force threshold.
[0051] The felt needle described herein can refer to a needle configured to push a single (or at least a few) fiber into soft tissue. The felt needle may include barbs and / or blunt tips for pushing the fiber in (see, for example, EP23159745.1).
[0052] As the felt needle moves to the extended position and extends from the orifice, the needle tip or barb may hook onto a single fiber and pull it into the soft tissue. The felt needle can then be retracted back to the retracted position.
[0053] The frequency of the reciprocating motion can be 1-200Hz, preferably 10-100Hz, most preferably 20-80Hz, and in one embodiment 40Hz. The amplitude of the reciprocating motion can be 1 to 25mm, particularly preferably 2 to 20mm, further preferably 3 to 16mm, and most preferably 4 to 10mm. These amplitudes are sufficient to cover a sufficiently thick feltable fabric while penetrating the target soft tissue and forming a sufficiently strong adhesion between the feltable material and the target area.
[0054] Another aspect of the invention relates to a method of manufacturing an implantable device for soft tissue repair or closure. The implantable device may be an implantable device as described above. The method includes the following steps: a. Provides a felt patch and a hydrogel material, wherein the felt patch is configured to be felted onto soft tissue to repair or close the soft tissue, and wherein the hydrogel material is configured to retain an active ingredient and biodegrade at a predetermined degradation rate to release the active ingredient, or wherein the hydrogel material is configured to release the active ingredient in response to a triggering factor. b. Combine the felt patch with the hydrogel material.
[0055] Combination may mean a connection as described above (e.g., mechanical connection, chemical connection, or thermal connection).
[0056] Preferably, joining the felt patch and the hydrogel material together includes felting the felt patch and the hydrogel material together, preferably using a felting apparatus, such as the felting apparatus described above.
[0057] Preferably, the method includes the following steps: loading an active ingredient into a hydrogelling material by hydrogelling the hydrogelling material, thereby forming a hydrogel loaded with the active ingredient. The hydrogelling material can swell with water. For example, the active ingredient can be dissolved in water.
[0058] The loading of the active ingredient can be performed before or after the implantation device.
[0059] The following figures disclose preferred embodiments by way of example only: Figure 1 A perspective view showing a first example of a device according to this disclosure is displayed.
[0060] Figure 2 A perspective view of a second example of a device according to this disclosure is shown.
[0061] Figure 3 A perspective view showing a third example of a device according to this disclosure is displayed.
[0062] Figure 4 A side view and a perspective view of a fourth example of an apparatus according to this disclosure are shown.
[0063] Figure 5 A perspective view showing a fifth example of a device according to this disclosure is displayed.
[0064] Figure 6 A perspective view showing a sixth example of an apparatus according to this disclosure is displayed.
[0065] Figure 7 A perspective view and a side view of a seventh example of an apparatus according to this disclosure are shown.
[0066] Figure 8 A perspective view showing an eighth example of a device according to this disclosure is displayed.
[0067] Figure 9 A perspective view showing a ninth example of a device according to this disclosure is displayed.
[0068] Figure 10 A perspective view and a side view of a tenth example of an apparatus according to this disclosure are shown.
[0069] Figure 11 A perspective view showing an eleventh example of a device according to this disclosure is displayed.
[0070] Figure 12 A perspective view showing a twelfth example of an apparatus according to this disclosure is displayed.
[0071] Figure 13 Showing will Figure 1 The method shown illustrates the connection of the device to soft tissue.
[0072] Figure 1 The device 1 of this disclosure is shown. Device 1 can be an implant. Device 1 includes a first layer 2 and a second layer 3 (or consists of a first layer 2 and a second layer 3). The first layer 2 is made of felt material. Any of the felt materials described above can be used. In this example, the felt material is made of PET fiber. The thickness of the first layer 2 is 1.8 mm, and the areal density is 300 g / m². The length and width of the first layer 2 can be adjusted according to the desired application. For example, in one example, i.e., in rotator cuff tendon repair, the width of the first layer can be 25 mm and the length can be 30 mm. The felt material is intended to be felted onto soft tissue. The breaking strength of the felt fiber is 6 cN / dtex. The breaking strength of a fiber (textile strength) is measured by dividing the breaking load of the fiber by its mass per unit length, and can be expressed in the International System of Units (SI) as N / tex or cN / dtex. tex is the unit of mass per unit length, with a corresponding mass per unit length of 1 g / km. The felt fibers can be made of any of the materials described above. In this example, the felt fibers in the first layer 2 have a fiber thickness of 5 to 25 micrometers or 15 to 20 micrometers (e.g., tolerance of 5 micrometers). The fiber length can be at least 40 or 50 millimeters (e.g., tolerance of 10 millimeters). Specifically, the fiber length can be 50 to 60 millimeters.
[0073] Felt can be prepared by known methods as follows: unpacking, fiber combing, optional mesh cross-over, pre-needling, post-needling, optional calendering, and winding of the nonwoven fabric.
[0074] The second layer (layer 3) is composed of a hydrogelling material. This hydrogelling material can be any of the materials described above. In this example, the hydrogelling material is carboxymethyl cellulose (CMC). CMC is a cross-linked hydrophilic material capable of locking in moisture. If the hydrogelling material retains moisture, it becomes a hydrogel. In this example, the thickness of the second layer (layer 3) can be approximately 1 mm. In other examples, the thickness of the second layer (layer 3) can be 0.5 to 3 mm, particularly 0.5 to 2 mm.
[0075] Hydrogel materials can be formed from monomers, initiators, and crosslinking agents. To control the heat of the polymerization reaction and the properties of the final hydrogel, a diluent, such as water or other aqueous solutions, can be used. The hydrogel block can then be washed to remove impurities remaining from the preparation process. These impurities may include unreacted monomers, initiators, crosslinking agents, and unwanted products from side reactions.
[0076] Hydrogels can be precisely controlled through various processing steps, such as polymerization, to meet specific applications. Some regulatory mechanisms are disclosed in Li, J., Mooney, D. Designing hydrogels for controlled drug delivery. Nat RevMater 1, 16071 (2016). Other drug delivery mechanisms are also disclosed in Cooper RC, Yang H. Hydrogel-basedocular drug delivery systems: Emerging fabrication strategies, applications, and bench-to-bedside manufacturing considerations. J Control Release. 2019 Jul 28;306:29-39.
[0077] Active ingredients (e.g., drugs) can be released using triggers. As mentioned above, triggers can be changes in pH, temperature, one or more enzymes, and mechanical stress (especially shear stress). Additionally, triggers can also be electric fields, as disclosed in Murdan S. Electro-responsive drug delivery from hydrogels. J Control Release. 2003 Sep 19;92(1-2):1-17. doi: 10.1016 / s0168-3659(03)00303-1. PMID: 14499181.
[0078] In one specific example, the CMC is loaded with a liquid nonsteroidal anti-inflammatory drug (NSAID, such as ibuprofen). The NSAID is then released in a controlled manner through the degradation of the second layer 3 of the device.
[0079] In this paper, the second layer 3 can also be referred to as the responsive layer because it can release the active ingredient in response to the triggering factors described herein. Correspondingly, the first layer 2 can be referred to as the non-responsive layer.
[0080] The thickness of the second layer (3) can be similar to that of the first layer (2). Its thickness can also be adjusted according to the required active ingredient loading, the expected mechanical load, and the available application space. The width and length of the second layer (3) can also be the same as those of the first layer (2). In some examples, the width and / or length of the second layer (3) can be smaller than that of the first layer (2). The first layer (2) can include edge areas not covered by the second layer (3) and can be directly attached to soft tissue.
[0081] As described above, the first layer 2 and the second layer 3 can be connected by stitch 4 (see...). Figure 12 ), or they can be laminated together.
[0082] Preferably, the first layer 2 and the second layer felt are bonded together. The hydrogel material may include fibers with a tensile strength of at least 0.5 cN / dtex. For example, Narendra Reddy, Yiqi Yang, Properties and potential applications of natural cellulose fibers from the bark of cotton stalks, Bioresource Technology, Volume 100, Issue 14, 2009, Pages 3563-3569, ISSN0960-8524 discloses a fiber made from natural cellulose fibers with a tensile strength of 2.9 g / den (approximately 2.6 cN / dtex). Such fibers can also be used in hydrogel materials. Kim GO, et al. An electrostatically crosslinked chitosan hydrogel as a drug carrier. Molecules 2012; 17: 13704–13711 discloses another hydrogel material with high-strength fibers suitable for drug loading.
[0083] Lam NYK, Zhang M, Guo H, Ho CP, and Li L disclosed additional fibers for use in hydrogel materials. Effect of fiber length and blending method on the tensile properties of ring spun chitosan–cotton blend yarns. Textile Research Journal. 2017;87(2):244-257.
[0084] Hydrogel materials with high-strength fibers are particularly advantageous because they can be bonded to tissue repair patches containing felt through felting. Through felting, two types of fibers (first layer 2 and second layer 3) interweave and intertwine. This forms a sufficient bond between first layer 2 and second layer 3. In some examples, first layer 2 and second layer 3 can be felted together during the manufacturing process using known textile manufacturing methods. In other examples, first layer 2 and second layer 3 can be manufactured and delivered as components (e.g., as kits). The user can then join first layer 2 and second layer 3 together using tools such as felting instruments.
[0085] PCT / EP2024 / 055924 discloses an exemplary felting device for connecting a first layer 2 and a second layer 3. The first layer 2 and the second layer 3 can be stacked on top of each other and felted using the movable needle disclosed in PCT / EP2024 / 055924.
[0086] In one exemplary manufacturing method, a first layer 2 and a second layer 3 are placed overlapping each other. Both layers can be placed on a suitable substrate through which felting needles can penetrate (e.g., synthetic sponge or foam material). These layers can be felted using the apparatus disclosed in PCT / EP2024 / 055924 or any other felting apparatus. For example, these layers can be felted manually (or machine-felted) using an array of felting needles (more than 2, e.g., 6). The felting needles can be gauge 42 and have barbs. The felting needles can be at least gauge 36. The spacing of the barbs can be very small.
[0087] First, the instrument 2 is felted from the side of the first layer 2, pushing the fibers of the first layer into the second layer. Then, the instrument can also be felted from the side of the second layer 3, pushing the fibers of the second layer into the first layer. The felting depth of the needle can be 10 mm or shallower, and the needle density (i.e., the number of needle pricks per unit area) can be in the range of 20 to 40 times / square centimeter.
[0088] In this way, the hydrogelled CMC (second layer 3) and the first layer 2 made of PET can be connected to each other to form a feltable device.
[0089] In some cases, hydrogel materials can be loaded with active ingredients before the device is introduced into the body. Since bodily fluids are present in most clinical applications, loading of the active ingredient should be done pre-implantation to prevent the hydrogel material from absorbing bodily fluids instead of the composition containing the active ingredient. However, non-liquid active ingredients can still be added after implantation.
[0090] Loading the active ingredient may involve immersing a hydrogel material in water to form a hydrogel layer. In one example process, the active ingredient is dissolved in water. The active ingredient is then loaded into the device by hydrogelling a second layer of the hydrogel material. Specifically, as... Figure 1 The device 1 shown can be swollen by injecting a liquid nonsteroidal anti-inflammatory drug (NSAID, such as ibuprofen) into a responsive CMC layer (e.g., in an operating room). Hydrogeling begins, and the responsive layer of the patch transforms into a gel-like state, with the drug contained within its cross-linked molecular chambers. The device can then be implanted and cover the internal wound using a felting technique (e.g., as described in PCT / EP2024 / 055924). The needle of the felting technique anchors the fibers of the first layer 2 and the second layer 3 into the soft tissue surrounding the wound, thus providing strong tissue reinforcement. The second layer (3) can be positioned between the soft tissue attachment surface and the first layer (2). The second layer (3) is in direct contact with the damaged soft tissue, further sealing the wound and potentially degrading slowly due to the action of bodily fluids. Simultaneously, the degradation process may cause the hydrogel to release the pre-loaded NSAID, helping to prevent inflammation and pain for the patient. If the second layer (3) is completely degraded, the unresponsive PET nonwoven fabric will maintain its mechanical strength to ensure that the open wound does not break open again.
[0091] Figure 13 An example of an implantation process is shown. Figure 13 The first image (labeled A) shows Figure 1 The device 1 shown is (more precisely, a double-layer patch). Device 1 is placed over the tear 6 across the soft tissue. The second image (labeled B) illustrates the surgical felting process using a surgical felting device 5, as described in PCT / EP2024 / 055924, which anchors PET and CMC fibers to the soft tissue surrounding the wound. The third image (labeled C) shows the tear after the second layer 3 has degraded, at which point the tear has healed (e.g., reduced in size). The non-degradable PET layer ensures the mechanical strength of the device. All example devices shown can be implanted in this manner. In some examples, the first layer 2 may also be degradable.
[0092] Figure 2An example of the second device 10 is shown. Similar to the first device 1, the second device 10 includes a first layer 12 and a second layer 13. They are manufactured in a similar manner to the first layer 2 and the second layer 13. However, the hydrogel material of the second layer 13 and the felt layer of the first layer 12 are not manufactured separately, but rather the hydrogel material is cross-linked within the first felt layer. For example, a first layer is provided and at least partially, preferably completely, immersed in a solution containing monomers, initiators, and cross-linking agents. The hydrogel can then cross-link within the first layer 12, thereby forming a mixed layer containing the hydrogel material and the felt layer. Thus, a combined layer of felt and hydrogel material is formed.
[0093] As another example, the second device 2 (comprising a felt layer and a hydrogel layer) can be formed by providing two separate layers of material; see [link to details]. Figure 1 Fibers can be mechanically mixed. For example, the fibers of the first and second layers can be combed together and then felted to form a single layer. This achieves mechanical mixing. Consequently, the fibers in the combined layer of felt and hydrogel material are entangled without chemical bonding.
[0094] Figure 3 The third example device 20 is shown. Figure 3 The device 20 shown has a first layer 22 similar to the first layer 2. The first layer 22 includes a plurality of holes 21, which may or may not be arranged along a grid pattern, such as... Figure 3 As shown. The width or diameter of each pore can reach 1 mm or larger. The pores 21 can be formed by cutting, punching or other methods. The pores 21 can be filled with hydrogel material 23. As described above, the hydrogel material 23 can form a hydrogel by hydrogelation, thereby loading the active ingredient.
[0095] Figure 4 The fourth example device 30 is shown. Device 30 and... Figure 1 The device 1 shown is similar, including a first layer 32 and a second layer 33. Furthermore, one or more edges 34 of the first layer 32 can be folded and secured (e.g., felted) in the folded position. In one example, as... Figure 4 As shown, two opposite edges can be folded. In another example, all four edges of the first layer 32 can be folded and secured (e.g., felted). This creates a groove for the second layer 33 and helps hold the second layer 33 in place after hydrogelling.
[0096] Figure 5 A portion of the fifth example device 40 is shown. Device 40 includes a third layer 43. (As shown) Figure 5 As shown, the third layer 43 forms a frame. This frame can enclose... Figure 1The second layer 3 of the device shown. Therefore, the second layer 3 can be fixed within the third layer 43. As... Figure 1 As shown, the first layer 2 is connected to the second layer, which can be framed by the third layer 43. Due to the presence of the frame, this structure can have higher mechanical strength. Furthermore, the degradation rate of the hydrogel may be slowed down when the third layer 43 surrounds the responsive second layer 3.
[0097] Figure 6 The sixth example device 50 is shown. This device 50 includes a first layer 52 and a second layer 53. The second layer 53 contains a columnar structure 54. This columnar structure 54 may be made of a non-responsive material, such as the felt material described above, and is attached to the first layer 52. Furthermore, the second layer 53 may contain a hydrogel material. In this example, the remainder of the second layer 53 may be similar to the second layer described above and surround the columnar structure 54. This creates a high-mechanical-strength anchor point at the center of the device. This implant may be beneficial for the repair of tendon tears.
[0098] The examples can be combined in any way. For example, a combined layer of felt and hydrogel material can replace the first layer in the illustrated example. In another example, a combined layer of felt and hydrogel material can replace the second layer of hydrogel material in the illustrated example.
[0099] Figure 7 A seventh example device 60 is shown. This device 60 includes a first layer 62 and a second layer 63, which are similar to the first layer 2 and the second layer 3. Furthermore, the second layer 63 includes a set of holes 64. These holes 64 can be used as follows... Figure 7 The distribution shown is along a grid, but it can also be distributed in any other manner. One or more markings may be provided on the opposite side of the instrument 60 to indicate the location of the holes 64. Therefore, when the instrument 60 is implanted into soft tissue using the felting method, more fibers of the first layer 62 are brought into the soft tissue, which may enhance the mechanical connection between the patch and the soft tissue.
[0100] Other examples may include three or more layers. For example, such as... Figure 8 As shown in (device 70), a second layer 73 (similar to second layer 3) can be disposed between the first layer 72 (similar to first layer 2) and the third layer 74. The third layer 74 can be similar to the first layer 72. For example, the third layer 74 can be made of a felt material with similar or different fibers. In particular, the third layer 74 is non-responsive. This device has particularly high mechanical stability and can release the active ingredient more slowly. In another variant, the first layer 72 can be sandwiched between two layers of hydrogel material, for example, sandwiched between two second layers 73. This device may be advantageous if different active ingredients need to be released from both sides of the device 70.
[0101] Figure 9 An alternative three-layer device 70 is shown. Instead of providing the first layer 72 and the third layer 74 as separate sheets, it can fold a felt sheet 75 around the hydrogelled material (second layer 73).
[0102] Figure 10 A tenth example device 80 is shown. This device 80 includes a first layer 82 (similar to first layer 2) and a second layer 83 (similar to second layer 3). Furthermore, a third layer 84 is (e.g., directly) attached to the first layer 82. The third layer 84 can be similar to the first layer 82. For example, the third layer 84 can be made of a felt material with similar or different fibers. In particular, the third layer 84 is responsive. The third layer 84 and the first layer 82 can form a capsule 85. As described above, the capsule 85 can be filled with a hydrogel material. The capsule 85 does not necessarily need to be filled with a hydrogel material. As an alternative or supplement, the capsule can also contain a liquid, solid, or gas as one or more active ingredients not fixed by the hydrogel material. The capsule 85 may include a shell made of a hydrogel material or hydrogel for sealing the capsule 85. The swelling of the hydrogel material forming the shell seals the capsule 85. Thus, a large amount of active ingredient can be released after the shell degrades.
[0103] Figure 11 The eleventh example device 90 is shown. Device 90 includes a first layer 92 (similar to first layer 2). Furthermore, device 90 includes several second layers 93. Each second layer 93 may be made of a material similar to second layer 3. Preferably, one or more second layers 93 are bonded together. Figure 2 The disclosed combination of layers is formed. One or more second layers 93 may extend longitudinally and may have, for example, Figure 11 The stripe shape is shown. These stripes can be interwoven with the first layer 92. In one example, these stripes can be interwoven along the intended stretching direction of the device 90. For example, if the device 90 is used for bridging such as Figure 13 At the fracture point shown, the tensile direction can extend across the fracture. Consequently, the responsive layer (second layer 93) increases in size, enabling it to hold a large amount of active ingredients, while the second layer 93 (non-responsive layer), made of nonwoven fabric (or felt), serves to fix the device in place and provide mechanical strength. These stripes can also interweave in multiple directions to form a mesh structure.
[0104] An example procedure using the disclosed apparatus may include the following steps.
[0105] 1. An active ingredient (e.g., water-soluble) is loaded onto one of the second layers and / or one of the hydrogelling materials, which may thus hydrogel.
[0106] 2. Transport the equipment to the target area.
[0107] 3. Secure the instruments using surgical felting instruments, as per reference. Figure 13 As stated above.
[0108] 4. The degradation of hydrogels leads to the precise release of active ingredients.
[0109] Another example procedure using the disclosed apparatus may include the following steps: 1. Transport the equipment to the target area.
[0110] 2. Secure the instruments using surgical felting instruments, as per reference. Figure 13 As stated above.
[0111] 3. Load the active ingredient into one of the second layers and / or one of the hydrogel materials.
[0112] 4. The degradation of hydrogels can enable the precise release of active ingredients.
[0113] Other aspects of this disclosure relate to the following: 1. An implantable medical device (1) for tissue repair or closure, wherein the device comprises: a. A patch (2) comprising felt for tissue repair or closure, and b. A hydrogel material (3) configured to retain an active ingredient, wherein the hydrogel material has a predetermined degradation rate and is biodegradable to release the active ingredient, or wherein the hydrogel material is configured to release the active ingredient in response to a triggering factor.
[0114] 2. The apparatus according to the first aspect, wherein the felt is configured to be feltable.
[0115] 3. The device according to aspect 1 or aspect 2, wherein the hydrogel material comprises or is made of natural polymers or synthetic polymers or combinations thereof.
[0116] 4. The device according to aspect 3, wherein the natural polymer comprises or is at least one of the following: cellulose, particularly bacterial cellulose or carboxymethyl cellulose (CMC), alginate, hyaluronic acid (HA), gelatin, agar, agarose, starch, chitosan, and fibrinogen.
[0117] 5. The apparatus according to aspect 3, wherein the synthetic polymer is at least one of the following: acrylamide, acrylic acid, a salt of acrylic acid, and 2-hydroxyethyl methacrylate, PHEMA.
[0118] 6. The apparatus according to any of the foregoing aspects, wherein the hydrogelling material forms a hydrogel and partially swells with water.
[0119] 7. The apparatus according to any one of the foregoing aspects, wherein the hydrogelling material forms a hydrogel, and wherein the hydrogel is completely swollen.
[0120] 8. The device according to one of the foregoing two aspects, wherein the hydrogel contains an active ingredient.
[0121] 9. The device according to the foregoing aspects, wherein the active ingredient is water-based, and the active ingredient is particularly dissolved in the water contained in the hydrogel.
[0122] 10. An apparatus according to one of the foregoing two aspects, wherein the active ingredient is dispersed, suspended and / or emulsified in water contained in the hydrogel.
[0123] 11. The device according to any one of the three aspects mentioned above, wherein the active ingredient comprises at least one of the following: growth factor, differentiation factor, anti-allergen, corticosteroid, stem cell, anti-adhesion molecule, analgesic, anti-inflammatory agent, antibiotic, insulin, hormone, hyaluronic acid, mRNA or mRNA-based drug, cytotoxic drug and vitamin.
[0124] 12. The device according to any of the foregoing aspects, wherein the active ingredient is at least one of the following: a drug, a bioactive ingredient, and a biological agent.
[0125] 13. The device according to any of the foregoing aspects, wherein the degradation rate of the hydrogel material is 2 to 48 hours, 2 to 14 days, 2 to 8 weeks or 1 to 18 months in vivo.
[0126] 14. An apparatus according to any of the foregoing aspects, wherein the triggering factor is at least one of the following: a change in pH, temperature, one or more enzymes, an electric field, and mechanical stress, particularly shear stress.
[0127] 15. The device according to one of the foregoing aspects, wherein the triggering factor causes degradation of the hydrogel material.
[0128] 16. The device according to any of the foregoing aspects, wherein the felt and the hydrogel material are directly connected to each other.
[0129] 17. The apparatus according to the foregoing aspect, wherein the connection method is at least one of mechanical connection, chemical connection and thermal connection.
[0130] 18. An apparatus according to any of the foregoing aspects, wherein the fibers of the hydrogel material and the fibers of the felt are interwoven and / or entangled, particularly felt together.
[0131] 19. The apparatus according to any of the foregoing aspects, wherein the hydrogel material comprises or is composed of fibers with a yield strength of at least 100, 250 or 500 kPa or at least 1, 10 or 100.
[0132] 20. The device according to any one of the foregoing aspects, wherein the hydrogel material comprises, or is composed of, fibers with a strength of 0.5 to 9 cN / dtex, particularly greater than 1 cN / dtex.
[0133] 21. An apparatus according to any of the foregoing aspects, wherein the felt has at least one of the following: a thickness of 1.0 to 1.8 mm, a surface weight of 200 to 400 g / m², a tensile strength of 400 to 800 N, and a stiffness of 50 to 250 N / mm².
[0134] 22. The device according to any one of the foregoing aspects, wherein the felt comprises or is composed of fibers with a strength of 3 to 9 cN / dtex.
[0135] 23. An instrument according to one of the foregoing aspects, wherein the hydrogel material and the felt are sewn together.
[0136] 24. The device according to any of the foregoing aspects, wherein the hydrogel material and the felt are interconnected by cross-linking the hydrogel material within the felt to form a composite hydrogel-felt material.
[0137] 25. An apparatus according to one of the foregoing aspects, wherein the hydrogel material and the felt are laminated together.
[0138] 26. The apparatus according to any one of the foregoing aspects, wherein the felt comprises or is composed of fibers of: polyethylene terephthalate (PET), polylactic acid (PLA), polyglutamic acid (PGA), polydioxane (PDO), polylactic acid-glycolic acid copolymer (PLGA), polytetrafluoroethylene (PTFE), polycaprolactone (PCL), chitosan, poly-D-lactic acid (PDLA), poly-DL-lactic acid (PDLLA), or poly-L-lactic acid, PLLA.
[0139] 27. The device according to any of the foregoing aspects, wherein the patch includes a first layer comprising a felt, wherein the first layer includes a plurality of pores, and wherein a hydrogel material is disposed within these pores.
[0140] 28. The device according to any of the foregoing aspects includes a first layer comprising a felt and a second layer comprising a hydrogelled material.
[0141] 29. The apparatus according to the foregoing aspect, wherein the first layer includes an edge region, and the edge region is folded around the second layer.
[0142] 30. The device according to one of the two aspects mentioned above, wherein the second layer further includes a frame formed of felt, wherein the hydrogelled material is contained within and surrounded by the frame.
[0143] 31. An apparatus according to any one of the foregoing three aspects, comprising a third layer, wherein the third layer comprises felt and / or hydrogelled material.
[0144] 32. The apparatus according to the foregoing aspect, wherein the second layer is sandwiched between the two layers comprising felt.
[0145] 33. The device according to one of the aforementioned two aspects, wherein the third layer comprises a hydrogel material and a bag is provided between the second and third layers.
[0146] 34. The device according to the foregoing aspect, wherein the bag contains an active ingredient, the active ingredient preferably comprising a solid or a gas, wherein the hydrogelling material forming the bag preferably swells at least partially to form a hydrogel.
[0147] 35. An apparatus according to any one of the foregoing aspects, wherein the apparatus comprises a first layer (comprising a felt) and a second layer (comprising a hydrogelled material), wherein the first layer comprises a first surface and an opposing second surface, and wherein the second layer comprises one or more stripes extending from the first surface to the second surface and back through the first layer.
[0148] 36. An instrument according to any of the foregoing aspects, wherein the instrument is configured for tendon repair, ligament repair, hernia repair, gastrointestinal surgery, or dental surgery.
[0149] 37. An instrument according to one of the foregoing aspects, wherein the instrument, in particular a hydrogel material, is configured to seal an internal wound.
[0150] 38. An instrument according to any of the foregoing aspects, wherein the internal wound is at least one of the following: a tendon or ligament tear, an opening in the abdominal wall that closes the abdominal cavity, or an opening in the gastrointestinal wall.
[0151] 39. A kit comprising the apparatus and felting apparatus according to one of the foregoing aspects.
[0152] 40. The kit according to the foregoing aspect, wherein the felting device includes a felting needle for pushing individual fibers into soft tissue.
[0153] 41. The kit according to the foregoing aspect, wherein the felt needle is reciprocating between an extended position and a retracted position, wherein in the extended position the working needle tip of the felt needle extends out of an orifice located at the distal end of the felting device, and in the retracted position the working needle tip does not extend out of the orifice.
[0154] 42. The kit according to the foregoing aspect, wherein the extended position and the retracted position are the end positions of the reciprocating motion.
[0155] 43. According to one of the aforementioned three aspects of the kit, wherein the felt needle is connected to the drive mechanism via a force limiting element, which limits the force applied to the felt needle by the drive mechanism within a predetermined force threshold during operation when the working needle tip moves from the retracted position to the extended position.
[0156] 44. A method of manufacturing an implantable device for soft tissue repair or closure, the device preferably being according to any one of the foregoing aspects, the method comprising the following steps: a. Provides a felt patch and a hydrogel material, wherein the felt patch is configured to be felted onto soft tissue to repair or close the soft tissue, and wherein the hydrogel material is configured to retain an active ingredient and biodegrade at a predetermined degradation rate to release the active ingredient, or wherein the hydrogel material is configured to release the active ingredient in response to a triggering factor. b. Combine the felt patch with the hydrogel material.
[0157] 45. The method according to the foregoing aspect, wherein connecting the felt patch and the hydrogel material to each other includes felting the felt patch and the hydrogel material together.
[0158] 46. The method according to any one of the preceding three aspects, comprising the step of loading the active ingredient into the hydrogelling material by hydrogelling the hydrogelling material to form a hydrogel loaded with the active ingredient.
[0159] 47. The method according to the foregoing aspect, wherein loading the active ingredient includes providing a water-based active ingredient and hydrogelling the hydrogelling material to form a hydrogel loaded with the active ingredient.
[0160] 48. The method according to one of the foregoing four aspects, wherein the step of loading the active ingredient is performed before or after implantation of the device.
Claims
1. An implantable medical device (1) for tissue repair or closure, wherein the device comprises: a. A patch (2), comprising felt for the repair or closure of the said tissue, and b. A hydrogel material (3) configured to retain an active ingredient, wherein the hydrogel material is biodegradable at a predetermined degradation rate to release the active ingredient, or wherein the hydrogel material is configured to release the active ingredient in response to a triggering factor.
2. The device according to claim 1, wherein, The felt is configured to be felted.
3. The device according to any one of the preceding claims, wherein, The hydrogel material forms a hydrogel and swells partially or completely with water, and contains the active ingredient.
4. The device according to any one of the preceding claims, wherein the active ingredient is water-based, and wherein the active ingredient is particularly soluble in the water contained in the hydrogel.
5. The device according to any one of the preceding claims, wherein the triggering factor causes the degradation of the hydrogel material.
6. The device according to any one of the preceding claims, wherein the fibers of the hydrogel material and the fibers of the felt are interwoven and / or entangled, particularly felt together.
7. The device according to any one of the preceding claims, wherein, The hydrogel material comprises or consists of fibers with a yield strength of at least 100, 250 or 500 kPa or at least 1, 10 or 100, and / or the hydrogel material comprises or consists of fibers with a tensile strength between 0.5 and 9 cN / dtex, particularly greater than 1 cN / dtex.
8. The device according to any one of the preceding claims, wherein, The hydrogel material and the felt are interconnected by cross-linking the hydrogel material within the felt to form a composite hydrogel-felt material.
9. The device according to any one of the preceding claims, wherein, The patch includes a first layer comprising the felt, wherein the first layer includes a plurality of pores, and wherein the hydrogel material is disposed within the pores.
10. The device according to any one of the preceding claims, comprising a first layer containing the felt and a second layer containing the hydrogelled material.
11. The device according to the preceding claim, wherein the second layer is sandwiched between the two layers comprising the felt.
12. The device according to any one of the preceding claims, wherein the device is configured for tendon repair, ligament repair, muscle repair, fascia repair, skin repair, hernia repair, gastrointestinal surgery, cardiac surgery, vascular surgery, or dental surgery.
13. A kit comprising the instrument and felting instrument according to any one of the preceding claims.
14. The kit according to the preceding claim, wherein, The felting device includes a felting needle configured to push individual fibers into soft tissue.
15. A method of manufacturing an implantable device for soft tissue repair or closure, the device preferably being the device according to any one of claims 1 to 12, the method comprising the following steps: a. Providing a felt patch and a hydrogel material, wherein the felt patch is configured to be felted onto soft tissue to repair or seal the soft tissue, and wherein the hydrogel material is configured to retain an active ingredient and biodegrade at a predetermined degradation rate to release the active ingredient, or wherein the hydrogel material is configured to release the active ingredient in response to a triggering factor, and b. Combine the felt patch with the hydrogel material.
Citation Information
Patent Citations
Felting set for attaching implants to soft tissue
WO2023232780A1
